Latvia - Import of Heterocyclic Compounds with Unfused Imidazole Ring
Since 2014, Latvia Import of Heterocyclic Compounds with Unfused Imidazole Ring grew 105.8% year on year. In 2019, the country was ranked number 75 comparing other countries in Import of Heterocyclic Compounds with Unfused Imidazole Ring with $978,042.98. Latvia is overtaken by Moldova, which was number 74 with $1,000,494 and is followed by Jordan at $965,390.14. United States topped the ranking with $239,540,700.09 in 2019, an increase of 112.7% compared to 2018. United Kingdom, Ireland and Japan respectively ranked number 2, 3 and 4 in this ranking. Oman witnessed the best average annual growth at +292.6% per year, while Iceland recorded the worst performance at -74.1% per year.
Loading...
Date | US Dollars |
---|---|
2019 | 978,042.98 |
2018 | 1,116,101.13 |
2017 | 392,717.78 |
2016 | 278,220.63 |
2015 | 172,996.31 |
Download all data from 1995 to 2019
How does Latvia rank in Import of Heterocyclic Compounds with Unfused Imidazole Ring?
# | 137 Countries | US Dollars | Last | YoY | 5‑years CAGR | ||
---|---|---|---|---|---|---|---|
1 |
#1
United States
|
239,540,700.09 | 2019 | +112.7 % | +5.1 % | View data | |
2 |
#2
United Kingdom
|
215,981,067.13 | 2019 | -9.7 % | +5.1 % | View data | |
74 |
#74
Moldova
|
1,000,494.00 | 2019 | +36.8 % | -17.4 % | View data | |
75 |
#75
Latvia
|
978,042.98 | 2019 | -12.4 % | +105.8 % | View data | |
76 |
#76
Jordan
|
965,390.14 | 2019 | -8.9 % | -15.6 % | View data |